422
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Target2DeNovoDrug: a novel programmatic tool for in silico-deep learning based de novo drug design for any target of interest

, ORCID Icon, &
Pages 7511-7516 | Received 13 Dec 2020, Accepted 26 Feb 2021, Published online: 11 Mar 2021

References

  • Bajorath, J., Kearnes, S., Walters, W. P., Meanwell, N. A., Georg, G. I., & Wang, S. (2020). Artificial intelligence in drug discovery: Into the great wide open. Journal of Medicinal Chemistry, 63, 8651–8652.
  • Barrett, S. J., & Langdon, W. B. (2006). Advances in the application of machine learning techniques in drug discovery, design and development. In Applications of soft computing (pp. 99–110). Springer.
  • Baskin, I. I. (2020). The power of deep learning to ligand-based novel drug discovery. Expert Opinion on Drug Discovery, 15(7), 755–764.
  • Batool, M., Ahmad, B., & Choi, S. (2019). A structure-based drug discovery paradigm. International Journal of Molecular Sciences, 20(11), 2783. https://doi.org/10.3390/ijms20112783
  • Bernardi, A., Faller, R., Reith, D., & Kirschner, K. N. (2019). ACPYPE update for nonuniform 1–4 scale factors: Conversion of the GLYCAM06 force field from AMBER to GROMACS. SoftwareX, 10, 100241. https://doi.org/10.1016/j.softx.2019.100241
  • Brown, N., Cambruzzi, J., Cox, P. J., Davies, M., Dunbar, J., Plumbley, D., & Sellwood, M. A. (2018). Big data in drug discovery. In Progress in medicinal chemistry (Vol. 57, pp. 277–356). Elsevier.
  • Chan, H. S., Shan, H., Dahoun, T., Vogel, H., & Yuan, S. (2019). Advancing drug discovery via artificial intelligence. Trends in Pharmacological Sciences, 40(8), 592–604. https://doi.org/10.1016/j.tips.2019.06.004
  • Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018). The rise of deep learning in drug discovery. Drug Discovery Today, 23(6), 1241–1250. https://doi.org/10.1016/j.drudis.2018.01.039
  • David, L., Thakkar, A., Mercado, R., & Engkvist, O. (2020). Molecular representations in AI-driven drug discovery: A review and practical guide. Journal of Cheminformatics, 12(1), 1–22. https://doi.org/10.1186/s13321-020-00460-5
  • Geoffrey, A. B., Madaj, R., Sanker, A., Valluri, P. P., Gracia, J., & Singh, H. (2020). Target2drug: A novel programmatic workflow to automate in silico drug discovery. ChemRxiv. https://doi.org/10.26434/chemrxiv.13262603.v1
  • Gupta, A., Müller, A. T., Huisman, B. J., Fuchs, J. A., Schneider, P., & Schneider, G. (2018). Generative recurrent networks for de novo drug design. Molecular Informatics, 37(1-2), 1700111. https://doi.org/10.1002/minf.201700111
  • Huang, H.-J., Yu, H. W., Chen, C.-Y., Hsu, C.-H., Chen, H.-Y., Lee, K.-J., Tsai, F.-J., & Chen, C. Y.-C. (2010). Current developments of computer-aided drug design. Journal of the Taiwan Institute of Chemical Engineers, 41(6), 623–635. https://doi.org/10.1016/j.jtice.2010.03.017
  • Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S. (2015). Role of computer-aided drug design in modern drug discovery. Archives of Pharmacal Research, 38(9), 1686–1701. https://doi.org/10.1007/s12272-015-0640-5
  • Mak, K.-K., & Pichika, M. R. (2019). Artificial intelligence in drug development: Present status and future prospects. Drug Discovery Today, 24(3), 773–780. https://doi.org/10.1016/j.drudis.2018.11.014
  • Sellwood, M. A., Ahmed, M., Segler, M. H., & Brown, N. (2018). Artificial intelligence in drug discovery. Future Medicinal Chemistry, 10(17), 2025–2028. https://doi.org/10.4155/fmc-2018-0212
  • Smalley, E. (2017). AI-powered drug discovery captures pharma interest. Nature Biotechnology, 35, 604–605.
  • Song, C. M., Lim, S. J., & Tong, J. C. (2009). Recent advances in computer-aided drug design. Briefings in Bioinformatics, 10(5), 579–591. https://doi.org/10.1093/bib/bbp023
  • Stephenson, N., Shane, E., Chase, J., Rowland, J., Ries, D., Justice, N., Zhang, J., Chan, L., & Cao, R. (2019). Survey of machine learning techniques in drug discovery. Current Drug Metabolism, 20(3), 185–193. https://doi.org/10.2174/1389200219666180820112457
  • Strieter, R. M., Kunkel, S. L., & Bone, R. C. (1993). Role of tumor necrosis factor-alpha in disease states and inflammation. Critical Care Medicine, 21(10 Suppl), S447–S463.
  • Taft, C. A., Da Silva, V. B., & Da Silva, C. H. T. D. P. (2008). Current topics in computer-aided drug design. Journal of Pharmaceutical Sciences, 97(3), 1089–1098. https://doi.org/10.1002/jps.21293
  • Van Drie, J. H. (2007). Computer-aided drug design: The next 20 years. Journal of Computer-Aided Molecular Design, 21(10-11), 591–601. https://doi.org/10.1007/s10822-007-9142-y
  • Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019). Concepts of artificial intelligence for computer-assisted drug discovery. Chemical Reviews, 119(18), 10520–10594. https://doi.org/10.1021/acs.chemrev.8b00728
  • Yang, Y., James Adelstein, S., & Kassis, A. I. (2012). Target discovery from data mining approaches. Drug Discovery Today, 17, S16–S23. https://doi.org/10.1016/j.drudis.2011.12.006
  • Yu, W., & MacKerell, A. D. (2017). Computer-aided drug design methods. In Antibiotics (pp. 85–106). Humana Press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.